Aurora Investment Counsel Invests $2.49 Million in Teleflex Incorporated (NYSE:TFX)

Aurora Investment Counsel bought a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,013 shares of the medical technology company's stock, valued at approximately $2,494,000. Teleflex makes up about 1.4% of Aurora Investment Counsel's portfolio, making the stock its 19th largest holding.

Several other institutional investors also recently bought and sold shares of TFX. Avior Wealth Management LLC lifted its stake in shares of Teleflex by 190.6% during the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock worth $38,000 after buying an additional 101 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Teleflex during the third quarter worth $40,000. True Wealth Design LLC lifted its stake in shares of Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock worth $41,000 after buying an additional 166 shares during the period. Banque Cantonale Vaudoise lifted its stake in shares of Teleflex by 184.8% during the third quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company's stock worth $56,000 after buying an additional 146 shares during the period. Finally, IFP Advisors Inc lifted its stake in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after buying an additional 217 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

Several research firms have recently commented on TFX. Truist Financial lowered their price objective on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research note on Monday, March 3rd. Royal Bank of Canada downgraded shares of Teleflex from an "outperform" rating to a "sector perform" rating and lowered their price objective for the stock from $220.00 to $155.00 in a research note on Friday, February 28th. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Morgan Stanley reduced their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a report on Wednesday, March 5th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Teleflex presently has an average rating of "Hold" and a consensus price target of $182.63.

Teleflex Stock Performance

TFX traded up $0.22 on Tuesday, reaching $139.97. The stock had a trading volume of 796,823 shares, compared to its average volume of 495,889. Teleflex Incorporated has a 12-month low of $128.55 and a 12-month high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The business's 50-day moving average price is $166.18 and its two-hundred day moving average price is $196.64. The company has a market cap of $6.49 billion, a P/E ratio of 27.83, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million during the quarter, compared to analysts' expectations of $813.24 million. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 0.97%. Teleflex's payout ratio is 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.